Publications by authors named "Pierre Cesaro"

Claim this Profile
N
Neuropathic Pain After Dental Implant Surgery: Literature Review and Proposed Algorithm for Medicosurgical Treatment.
Alp Alantar, Jacques-Christian Béatrix, Guy Marti, Guy Princ, Nathalie Rei, Pierre Cesaro

J Oral Implantol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical routine use of dopamine transporter imaging in 516 consecutive patients.
Claire Thiriez, Emmanuel Itti, Gilles Fénelon, Eva Evangelista, Michel Meignan, Pierre Cesaro

J Neurol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ehlers-Danlos and dystonia. Positive effects of amantadine].
Claude Hamonet, Pierre Césaro

Presse Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
Stéphane Palfi, Jean Marc Gurruchaga, G Scott Ralph, Helene Lepetit, Sonia Lavisse, Pierre Cesaro

Lancet· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial.
Stéphane Haïk, Gabriella Marcon, Alain Mallet, Mauro Tettamanti, Arlette Welaratne, Pierre Cesaro

Lancet Neurol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Ventricular orexin-A (hypocretin-1) levels correlate with rapid-eye-movement sleep without atonia in Parkinson's disease.
Agathe Bridoux, Stephane Moutereau, Ala Covali-Noroc, Laurent Margarit, Stephane Palfi

Nat Sci Sleep· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson's disease.
Gilles Fénelon, Colette Goujon, Jean-Marc Gurruchaga, Pierre Cesaro, Bechir Jarraya

Parkinsonism Relat Disord· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis.
Hassan Hosseini, Tomasz Mandat, Emmanuelle Waubant, Yves Agid, Catherine Lubetzki, Pierre Cesaro

Neurosurgery· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF).
Elodie Passeri, Chiara Villa, Maryline Couette, Emmanuel Itti, Pierre Brugieres, Pierre Cesaro

J Inorg Biochem· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can nicotine be used medicinally in Parkinson's disease?
Claire Thiriez, Gabriel Villafane, Frédérique Grapin, Gilles Fenelon, Philippe Remy, Pierre Cesaro

Expert Rev Clin Pharmacol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Psychological and behavioural disorders in Parkinson's disease].
Gilles Fénelon, Pierre Césaro

Bull Acad Natl Med· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.
Olivier Rascol, Jean-Philippe Azulay, Olivier Blin, Anne-Marie Bonnet, Christine Brefel-Courbon

Mov Disord· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction.
Maryline Couette, Marie-Françoise Boisse, Patrick Maison, Pierre Brugieres, Pierre Cesaro

J Inorg Biochem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopamine transporter imaging under high-dose transdermal nicotine therapy in Parkinson's disease: an observational study.
Emmanuel Itti, Gabriel Villafane, Zoulikha Malek, Pierre Brugières, Daniela Capacchione, Pierre Cesaro

Nucl Med Commun· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterotopagnosia: When I point at parts of your body.
Laurent Cleret de Langavant, Iris Trinkler, Pierre Cesaro, Anne-Catherine Bachoud-Lévi

Neuropsychologia· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The future for nerve cell transplantation?].
Pierre Cesaro

Rev Prat· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
Jean-Pascal Lefaucheur, Jean-Marc Gurruchaga, Bernard Pollin, Florian von Raison, Nabil Mohsen, Pierre Cesaro

Eur Neurol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the striatum in sentence processing: evidence from a priming study in early stages of Huntington's disease.
Marc Teichmann, Emmanuel Dupoux, Pierre Cesaro, Anne-Catherine Bachoud-Lévi

Neuropsychologia· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrophysiological deterioration over time in patients with Huntington's disease.
Jean-Pascal Lefaucheur, Isabelle Ménard-Lefaucheur, Patrick Maison, Sophie Baudic, Pierre Cesaro

Mov Disord· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
Alexandre Castro-Caldas, Paul Delwaide, Wolfgang Jost, Marcelo Merello, Adrian Williams, Pierre Cesaro

Mov Disord· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study.
Anne-Catherine Bachoud-Lévi, Véronique Gaura, Pierre Brugières, Jean-Pascal Lefaucheur, Marie-Françoise Boissé, Pierre Cesaro

Lancet Neurol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the striatum in rule application: the model of Huntington's disease at early stage.
Marc Teichmann, Emmanuel Dupoux, Sid Kouider, Pierre Brugières, Marie-Françoise Boissé, Pierre Cesaro

Brain· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
Jean-Pascal Lefaucheur, Xavier Drouot, Florian Von Raison, Isabelle Ménard-Lefaucheur, Pierre Cesaro

Clin Neurophysiol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The design of clinical trials for cell transplantation into the central nervous system.
Pierre Cesaro

NeuroRx· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Striatal neural grafting improves cortical metabolism in Huntington's disease patients.
Véronique Gaura, Anne-Catherine Bachoud-Lévi, Maria-Joao Ribeiro, Jean-Paul Nguyen, Vincent Frouin, Pierre Cesaro

Brain· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis